TIDMDPH TIDM80GT
RNS Number : 8889Z
Dechra Pharmaceuticals PLC
16 January 2024
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB0009633180
Issuer Name
DECHRA PHARMACEUTICALS PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
JPMorgan Chase & Co.
City of registered office (if applicable)
Country of registered office (if applicable)
US
4. Details of the shareholder
Name City of registered office Country of registered office
J.P. Morgan Securities plc
=========================== ==============================
5. Date on which the threshold was crossed or reached
12-Jan-2024
6. Date on which Issuer notified
16-Jan-2024
7. Total positions of person(s) subject to the notification
obligation
% of voting rights % of voting rights Total of both in % Total number of
attached to shares through financial (8.A + 8.B) voting rights held
(total of 8.A) instruments (total in issuer
of 8.B 1 + 8.B 2)
Resulting situation
on the date on
which threshold
was crossed or
reached 8.271846 0.315854 8.587700 9781946
====================== ====================== ====================== ======================
Position of
previous
notification (if
applicable) 7.916218 0.297637 8.213855
====================== ====================== ====================== ======================
8. Notified details of the resulting situation on the date on
which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares Number of direct Number of indirect % of direct voting % of indirect voting
ISIN code(if possible) voting rights (DTR5.1) voting rights rights (DTR5.1) rights (DTR5.2.1)
(DTR5.2.1)
GB0009633180 9422134 8.271846
====================== ====================== ====================== ======================
Sub Total 8.A 9422134 8.271846%
============================================== ==============================================
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial Expiration date Exercise/conversion period Number of voting rights % of voting rights
instrument that may be acquired if
the instrument is
exercised/converted
Sub Total 8.B1
=========================================== ========================= ==================
8B2. Financial Instruments with similar economic effect
according to (DTR5.3.1R.(1) (b))
Type of financial Expiration date Exercise/conversion Physical or cash Number of voting % of voting rights
instrument period settlement rights
Cash-settled
Equity Swap 20/02/2024 20/02/2024 Cash 6220 0.005451
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 04/03/2024 04/03/2024 Cash 5090 0.004468
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 27/06/2024 27/06/2024 Cash 880 0.000772
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 31/07/2024 31/07/2024 Cash 39012 0.034249
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 17/10/2024 17/10/2024 Cash 68288 0.059951
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 04/11/2024 04/11/2024 Cash 17 0.000014
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 20/11/2024 20/11/2024 Cash 500 0.000438
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 27/12/2024 27/12/2024 Cash 4313 0.003783
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 22/01/2025 22/01/2025 Cash 202956 0.178178
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 04/02/2025 04/02/2025 Cash 5556 0.004870
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 11/02/2025 11/02/2025 Cash 4200 0.003685
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 17/02/2025 17/02/2025 Cash 15886 0.013944
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 18/06/2027 18/06/2027 Cash 6891 0.006049
================ ==================== ================== ================== ==================
Cash-settled
Equity Swap 30/05/2028 30/05/2028 Cash 3 0.000002
================ ==================== ================== ================== ==================
Sub Total 8.B2 359812 0.315854%
================== ==================
9. Information in relation to the person subject to the
notification obligation
2. Full chain of controlled undertakings through which the
voting rights and/or the financial instruments are effectively held
starting with the ultimate controlling natural person or legal
entities (please add additional rows as necessary)
Ultimate controlling Name of controlled % of voting rights if % of voting rights Total of both if it
person undertaking it equals or is through financial equals or is higher
higher than the instruments if it than the notifiable
notifiable threshold equals or is higher threshold
than the notifiable
threshold
J.P. Morgan
JPMorgan Chase & Co. Securities plc 8.245585 8.561439%
======================= ===================== ===================== ======================
JPMorgan Chase & Co. J.P. Morgan
Securities LLC
======================= ===================== ===================== ======================
JPMorgan Chase & Co. J.P. Morgan SE
======================= ===================== ===================== ======================
JPMorgan Chase & Co. J.P. Morgan Markets
Limited
======================= ===================== ===================== ======================
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
Chain of controlled undertakings:
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan Capital Holdings Limited (100%)
J.P. Morgan Securities plc (100%)
JPMorgan Chase & Co.
JPMorgan Chase Holdings LLC (100%)
J.P. Morgan Broker-Dealer Holdings Inc. (100%)
J.P. Morgan Securities LLC (100%)
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan SE (100%)
JPMorgan Chase & Co.
JPMorgan Chase Holdings LLC (100%)
Bear Stearns Irish Holdings LLC (100%)
J.P. MORGAN FINANCIAL INVESTMENTS LIMITED (100%)
J.P. MORGAN MARKETS LIMITED (100%)
12. Date of Completion
16-Jan-2024
13. Place Of Completion
London, United Kingdom
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
HOLUNSSRSAUAAAR
(END) Dow Jones Newswires
January 16, 2024 09:43 ET (14:43 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Oct 2024 to Nov 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Nov 2023 to Nov 2024
